| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Dept of Public Health Sciences, Karolinska Institute, 2 Dept of Occupational and Environmental Health, Stockholm County Council, 3 Dept of Nuclear Medicine, Institution of Oncology-Pathology, Karolinska Hospital, 4 The Swedish Radiation Protection Authority, 5 The Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden. 6 Intelligent Aerosol Medicine, InAMed GmbH, and 7 GSF National Research Centre for Environment and Health, Institute for Inhalation Biology, Gauting and Munich, Germany.
CORRESPONDENCE: P. Wiebert, Dept of Occupational and Environmental Health, Norrbacka, Karolinska Hospital, SE-171 76 Stockholm, Sweden. Fax: 46 8334333. E-mail: pernilla.wiebert{at}ki.se
Keywords: Air pollution, circulation, clearance, ultrafine particles
Received: September 5, 2005
Accepted April 13, 2006
 |
ABSTRACT |
|---|
 TOP ABSTRACT MATERIALS AND METHODSRESULTSDISCUSSIONACKNOWLEDGEMENTSREFERENCES |
|---|
The present authors have developed an improved method to produce ultrafine particles with more stable radiolabelling and defined particle size range. Fifteen subjects inhaled technetium 99m (99mTc)-labelled carbonaceous particles of 100 nm in size. Radioactivity over the lung was followed for 70 h. The clearance of these ultrafine particles from the lungs and specifically translocation to the circulation was tested.
Lung retention for all subjects at 46 h was mean±SD 99±4.6%. Cumulative leaching of 99mTc activity from the particles was 2.6±0.96% at 70 h. The 24-h activity leaching in urine was 1.0±0.55%.
No evidence of a quantitatively important translocation of 100-nm particles to the systemic circulation from the lungs was found. More research is needed to establish if the 
1% cleared activity originates from leached activity or insoluble translocated particles, and whether a few per cent of translocated particles is sufficient to cause harmful effects.
Epidemiological studies provide evidence that air pollution contributes to systemic as well as pulmonary diseases and reactive airway effects 1–6. These findings pertain to elderly people and susceptible persons with underlying diseases of various origins 7. Ultrafine particles (<100 nm diameter) represent a substantial component of the particulate matter in ambient air. Ultrafine particles are more toxic and induce more severe inflammation than larger particles 8. The mechanisms underlying the effects are largely unknown, but autonomic regulation of the heartbeat, inflammation and systemic coagulation effects, and direct metal toxicity to the heart muscle are proposed mechanisms 7, 9, 10. It is essential to establish if insoluble particles can enter the systemic circulation, or if particles’ specific effects are initiated in the lung.
Recently, Nemmar et al. 11 exposed five human subjects by inhalation to technetium 99m (99mTc)-labelled ultrafine particles and observed translocation of 99mTc into the blood compartment. Leaching of the label affected the result due to the difficulty in differentiating between the solute label and labelled ultrafine particles in blood and extrapulmonary organs.
The aim of the study was to examine whether there is a significant uptake of ultrafine particles (100 nm) into the systemic circulation, by measuring pulmonary retention and activity over the liver. The test particles were generated with a new modified method developed by the research groups involved.
|
MATERIALS AND METHODS |
|---|
|
TOPABSTRACTMATERIALS AND METHODSRESULTSDISCUSSIONACKNOWLEDGEMENTSREFERENCES |
|---|
Modifications
Leaching-free particles of a controlled size were required, and to produce these, the following were carried out: 1) sodium was eliminated from the 99mTc elute; 2) the argon gas was purified; 3) the particle aerosol was diluted to reduce coagulation; and, for modulation of particle size: 4) evaporation time was modified; and 5) temperature was modified. The method was developed for the current study and is described by Möller et al. 12.
Exposure
A fresh aerosol of radiolabelled carbonaceous particles of 100-nm diameter was produced for every subject using a Technegas GeneratorTM (fig. 1
).
|
Measurement of retention and clearance
Activity in the chest region was measured with the subject in a supine position, immediately after aerosol inhalation and after 2, 24, 46 and 70 h (fig. 2). In the first three measurements, planar images were performed with a gamma camera (TRIAD XLT 20; Trionix, Twinsburg, OH, USA), and the subsequent measurements were made with a whole-body scanner with sodium iodide (NaI) detectors (Harshaw, Paris, France) 13.
|
A whole-lung region of interest (ROI) was placed around the borders of each lung. Retention was computed from combined counts of left and right whole-lung ROIs.
Estimates of leaching
Activity leached from the particles was estimated by the following methods: 1) estimating the number of aerosol particles collected on a filter; and 2) measurement of activity in urine.
Method 1
After exposure, the particles of the remaining aerosol in the flexible bag were collected on a 0.2-µm pore-size membrane filter TF (PTFE; Pall Corporation). Leaching studies of each aerosol were performed using the membrane filter with the collected particles, mounted in an open filter holder between two 0.025-µm pore-size nitrate cellulose filters (Schleicher & Schuell, Dassel, Germany) forming a sandwich tightly closed at its perimeter by the filter holder. The filter sandwich was submersed in 1 L of 0.9% NaCl solution. At 0.3, 1.5, 21, 45 and 70 h, the filter sandwich was temporarily removed for activity measurement in the solution.
Method 2
The second estimate of leaching was performed by measuring activity in urine 14, 15 from the subjects sampled during the first 24 h after exposure.
Subjects
Fifteen subjects, including six healthy nonsmokers, five subjects with asthma symptoms and four asymptomatic smokers (nine males and six females; 46–74 yrs old) participated in the current study. Median (range) pulmonary function values (forced expiratory volume in one second/forced vital capacity) were as follows: for healthy subjects, 83 (74–86); for asthmatics, 78 (56–82); and for smokers, 78 (52–85). There were no significant differences in pulmonary function between healthy and affected lungs (p = 0.166).
Statistical analysis
Values are presented as mean±SD, unless otherwise stated.
|
RESULTS |
|---|
|
TOPABSTRACTMATERIALS AND METHODSRESULTSDISCUSSIONACKNOWLEDGEMENTSREFERENCES |
|---|
).
|
). No activity could be detected in the liver or thyroid during the first and second days. The deposition fraction was 41±10%. The median value for tidal volume during exposure was 1.8 L (0.8–3.3).
|
. Cumulative leaching from particles at 70 h was 2.6±0.96%. Activity leaching in urine was 1.0±0.55% during the first 24 h. In contrast, leaching from particles produced with the standard Technegas GeneratorTM method was 11% within 24 h (fig. 5). Individual leaching did not correlate to individual retention.
|
|
DISCUSSION |
|---|
|
TOPABSTRACTMATERIALS AND METHODSRESULTSDISCUSSIONACKNOWLEDGEMENTSREFERENCES |
|---|
In the current study, the authors were able to produce aerosols of ultrafine carbonaceous particles labelled with 99mTc isotopes. Particle coagulation was greatly reduced, which is clear from the results of size monitoring before and after particle inhalation. Leaching estimates were assessed for all exposures. Results on retention, activity in urine and leaching from particles indicate limited leaching of activity.
Lung retention was measured for 70 h with very sensitive detectors, which corresponds to a 3,300-fold natural decay in 99mTc activity. The present authors think this can explain the uncertainty seen in the measurement at 70 h.
The current study shows that a convenient way to study ultrafine particles in the human lungs is to use radiolabelled particles, such as particles generated with the Technegas GeneratorTM. The standard use, however, has limitations. Presence of oxygen during particle generation produces pertechnetate (99mTcO4-), which instantaneously leaches off the labelled particles in body fluids 17–19. Pertechnetate assembles in the thyroid and is excreted with urine within days 14, 15. This may contribute to the results interpreted as translocation in the study by Nemmar et al. 11, in which thyroid glands and bladder were visible in the whole body scan. Particle-bound 99mTc, on the contrary, accumulates in the liver and only a limited amount is found in the bladder 20. Another problem with the standard method is that particle size grows rapidly due to large coagulation rates. Primary Technegas particles are 5–20 nm, but coagulate to a median diameter of >100 nm within minutes if not diluted into filtered air 21–23.
No retention results are reported in the study by Nemmar et al. 11, but they found 8% of the inhaled activity in the liver almost immediately after inhalation when using particles comparable to those produced with a Technegas GeneratorTM under standard conditions. In the current study, no activity was found in the liver immediately after exposure or on day 2. This can be due to sensitivity problems, as only a small percentage of the activity escaped from the lung in the current study. The results of Nemmar et al. 11, however, present evidence of leaching activity from the particles, and it is not clear whether the activity in the liver is bound to primary carbon particles or plasma proteins.
Another human study reporting declining retention values was performed by Brown et al. 24, who assessed lung retention in healthy and chronic obstructive pulmonary disease patients. The ultrafine carbon particles were generated using a commercially available generator, arcing between graphite electrodes under a high-purity argon atmosphere. Lung retention was 86% 1 day after deposition, but because leaching from the particles was substantial (23%), 24-h retentions were corrected based on measured in vitro leaching of label from the particles. Another difference from the current study is that the subjects inhaled smaller particles (60 nm) under realistic resting breathing conditions (i.e. not deep breathing with breath-holding), which may have resulted in a greater fraction of particles depositing on bronchial airways, i.e. particles that might clear by mucociliary clearance.
Particle-bound and free activity in blood samples was not examined in the current study; this would have added valuable information about possible translocation. However, it is uncertain if the low levels of translocated activity seen in the current study were sufficient to be detected in the blood. In a recent study by Mills et al. 25, humans were exposed to 108-nm Technegas particles produced by the standard method. Retention was measured for a shorter time period than in the current study; at the last measurement at 6 h, retention was 95.6%. In vitro leaching from the particles was slightly higher: 5% after 6 h versus 2.6% after 70 h in the current study. Besides retention, and similar to the approach of Nemmar et al. 11, Mills et al. 25 also measured blood activity and performed thin layer chromatography; however, in contrast to Nemmar et al. 11, Mills et al. 25 found the small amount of blood-borne 99mTc to be unbound and thus concluded that translocation of particles from the lungs to the circulation is negligible, a result confirmed by the current study.
In an animal study by Kreyling et al. 16 using 192Ir particles, the fraction of translocated particles from the lung to extrapulmonary organs was only <0.002 and 0.001 for deposited 15- and 80-nm particles, respectively. The 192Ir particles did not leach and the results of Kreyling et al. 16 are in agreement with the current findings.
Conclusions
There is no evidence of a quantitatively important (mass-based) translocation of 100-nm particles to the systemic circulation from either healthy or affected lungs. The present authors therefore challenge earlier studies stipulating a rapid and substantial uptake of ultrafine particles; results of earlier studies may be a consequence of technical shortcomings.
More research is needed to establish if the 1% cleared activity originates from leached activity or insoluble translocated particles, and whether a few per cent of translocated particles is sufficient to cause harmful effects. The hypothesis that systemic access of ultrafine insoluble particles may generally induce adverse reactions in the cardiovascular system and liver, leading to the onset of cardiovascular disease, requires further detailed and differentiated consideration.
|
ACKNOWLEDGEMENTS |
|---|
|
TOPABSTRACTMATERIALS AND METHODSRESULTSDISCUSSIONACKNOWLEDGEMENTSREFERENCES |
|---|
|
REFERENCES |
|---|
|
TOPABSTRACTMATERIALS AND METHODSRESULTSDISCUSSIONACKNOWLEDGEMENTSREFERENCES |
|---|
This article has been cited by other articles:
|
|
 |
|
  R. L. Rouse, G. Murphy, M. J. Boudreaux, D. B. Paulsen, and A. L. Penn Soot Nanoparticles Promote Biotransformation, Oxidative Stress, and Inflammation in Murine Lungs Am. J. Respir. Cell Mol. Biol., August 1, 2008; 39(2): 198 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Muhlfeld, B. Rothen-Rutishauser, F. Blank, D. Vanhecke, M. Ochs, and P. Gehr Interactions of nanoparticles with pulmonary structures and cellular responses Am J Physiol Lung Cell Mol Physiol, May 1, 2008; 294(5): L817 - L829. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Geiser, M. Casaulta, B. Kupferschmid, H. Schulz, M. Semmler-Behnke, and W. Kreyling The Role of Macrophages in the Clearance of Inhaled Ultrafine Titanium Dioxide Particles Am. J. Respir. Cell Mol. Biol., March 1, 2008; 38(3): 371 - 376. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Kaufman Air Pollution and Mortality: Are We Closer to Understanding the How? Am. J. Respir. Crit. Care Med., August 15, 2007; 176(4): 325 - 326. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Petersson, A. Sanchez-Crespo, S. A. Larsson, and M. Mure Physiological imaging of the lung: single-photon-emission computed tomography (SPECT) J Appl Physiol, January 1, 2007; 102(1): 468 - 476. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
) were performed on the remaining aerosol particles from each exposure occasion. The cumulative amount of activity leached from the particles was measured at approximately the same time interval as lung measurements were taken. In an additional leaching test, activity was measured in urine samples provided by the subjects during the first 24 h following exposure.
). The decrease in particle number concentration and the slight shift of the spectrum to larger sizes reflects the dynamic changes of coagulation and wall losses of the aerosol within the two time-points of measurement.
; n = 15, except at 21 h (n = 14) and 70 h (n = 7)) is compared with the standard method (
; n = 2). Twenty-four hour cumulative urine excretion after particle exposure (•; n = 15) is also shown for particles generated with the modified method (n = 2). Error bars indicate SD.